Physiology · Pathophysiology
The kidneys are vital organs responsible for maintaining homeostasis through filtration, reabsorption, secretion, and excretion. Renal disorders disrupt these processes, leading to electrolyte imbalances, acid-base disturbances, and accumulation of metabolic waste. Understanding the pathophysiology of renal disorders requires a firm grasp of renal physiology, including glomerular filtration, tubular function, and hormonal regulation.
Renal disorders can be broadly categorized into glomerular, tubular, interstitial, and vascular diseases. Each category affects distinct components of the nephron, leading to unique clinical presentations. This section explores the physiological mechanisms underlying these disorders and their systemic consequences.
The glomerulus filters blood based on size and charge selectivity, allowing small solutes and water to pass while retaining larger molecules like proteins. Glomerular disorders, such as glomerulonephritis or diabetic nephropathy, disrupt this barrier, leading to proteinuria and hematuria. Inflammatory or immune-mediated damage to the glomerular basement membrane alters filtration dynamics, reducing glomerular filtration rate (GFR) and causing renal insufficiency.
The renal tubules reabsorb essential solutes and water while secreting waste products. Disorders like Fanconi syndrome or renal tubular acidosis impair these processes, leading to electrolyte imbalances (e.g., hypokalemia, hyperchloremia) and metabolic acidosis. Proximal tubule dysfunction often results in glycosuria, aminoaciduria, and phosphaturia, while distal tubule defects primarily affect acid-base regulation.
Interstitial nephritis, often caused by infections or drug toxicity, leads to inflammation and fibrosis of the renal interstitium, impairing tubular function. Vascular disorders, such as renal artery stenosis or hypertensive nephrosclerosis, reduce renal perfusion, triggering renin-angiotensin-aldosterone system (RAAS) activation. Chronic ischemia results in glomerulosclerosis and progressive loss of nephrons, culminating in chronic kidney disease (CKD).
The kidneys play a central role in hormonal regulation, producing erythropoietin (EPO) and activating vitamin D. In CKD, reduced EPO production leads to anemia, while impaired vitamin D activation causes secondary hyperparathyroidism and renal osteodystrophy. Additionally, dysregulation of RAAS contributes to hypertension and fluid retention, exacerbating renal and cardiovascular complications.
AKI is characterized by a sudden decline in GFR, often due to prerenal (e.g., hypovolemia), intrinsic (e.g., acute tubular necrosis), or postrenal (e.g., obstruction) causes. In contrast, CKD involves progressive, irreversible nephron loss, leading to uremia, fluid overload, and metabolic derangements. Both conditions share common pathophysiological pathways, including oxidative stress, inflammation, and fibrosis, but differ in their clinical course and management.
Renal disorders disrupt glomerular filtration, tubular reabsorption/secretion, and hormonal regulation, leading to systemic complications. Glomerular diseases primarily cause proteinuria and hematuria, while tubular disorders result in electrolyte and acid-base imbalances. Interstitial and vascular diseases impair renal perfusion and function, contributing to CKD progression.
Early detection of renal dysfunction is critical for preventing irreversible damage. Clinical markers such as serum creatinine, GFR, and urinalysis (e.g., proteinuria, casts) help diagnose and monitor renal disorders. Management strategies focus on addressing underlying causes, controlling blood pressure, and mitigating complications like anemia and bone disease in CKD.
Understanding renal pathophysiology requires integrating knowledge of nephron function, hormonal regulation, and systemic effects. Disruptions in these processes lead to clinical manifestations such as edema, hypertension, and metabolic acidosis, emphasizing the kidneys' central role in maintaining homeostasis.